XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balances (in shares) at Dec. 31, 2019   163,274,880      
Balances at Dec. 31, 2019 $ 71,711 $ 0 $ 1,752,048 $ (27,468) $ (1,652,869)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense 13,869   13,869    
Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)   868,857      
Shares issued upon vesting of restricted stock units and for exercises of stock options 69   69    
Shares issued for accrued compensation (in shares)   1,880,405      
Shares issued for accrued compensation 5,100   5,100    
Shares issued as payment for services (in shares)   413,911      
Shares issued as payment for services 1,006   1,006    
Shares issued upon conversion of long-term debt (in shares)   6,293,402      
Shares issued upon conversion of long-term debt 31,827   31,827    
Shares issued in private placement or in public offering, net of issuance costs (in shares)   5,972,696      
Shares issued in private placement or in public offering, net of issuance costs 35,000   35,000    
Net loss (128,860)       (128,860)
Release of cumulative translation adjustments to loss from discontinued operations 26,957     26,957  
Other comprehensive income (loss) 1,873     1,873  
Balances (in shares) at Sep. 30, 2020   178,704,151      
Balances at Sep. 30, 2020 58,552 $ 0 1,838,919 1,362 (1,781,729)
Balances (in shares) at Jun. 30, 2020   172,285,932      
Balances at Jun. 30, 2020 49,542 $ 0 1,802,413 (650) (1,752,221)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense 4,600   4,600    
Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)   28,389      
Shares issued upon vesting of restricted stock units and for exercises of stock options 3   3    
Shares issued for accrued compensation (in shares)   75,000      
Shares issued for accrued compensation 0        
Shares issued as payment for services (in shares)   21,428      
Shares issued as payment for services 76   76    
Shares issued upon conversion of long-term debt (in shares)   6,293,402      
Shares issued upon conversion of long-term debt 31,827   31,827    
Net loss (29,508)       (29,508)
Release of cumulative translation adjustments to loss from discontinued operations 0        
Other comprehensive income (loss) 2,012     2,012  
Balances (in shares) at Sep. 30, 2020   178,704,151      
Balances at Sep. 30, 2020 $ 58,552 $ 0 1,838,919 1,362 (1,781,729)
Balances (in shares) at Dec. 31, 2020 187,663,207 187,663,207      
Balances at Dec. 31, 2020 $ 67,174 $ 0 1,886,567 3,997 (1,823,390)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense 11,462   11,462    
Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)   1,750,521      
Shares issued upon vesting of restricted stock units and for exercises of stock options 603   603    
Shares issued as payment for services (in shares)   74,771      
Shares issued as payment for services 577   577    
Shares issued in private placement or in public offering, net of issuance costs (in shares)   17,250,000      
Shares issued in private placement or in public offering, net of issuance costs 121,045   121,045    
Net loss (67,132)       (67,132)
Release of cumulative translation adjustments to loss from discontinued operations 0        
Other comprehensive income (loss) $ (2,482)     (2,482)  
Balances (in shares) at Sep. 30, 2021 206,738,499 206,738,499      
Balances at Sep. 30, 2021 $ 131,247 $ 0 2,020,254 1,515 (1,890,522)
Balances (in shares) at Jun. 30, 2021   206,580,928      
Balances at Jun. 30, 2021 159,196 $ 0 2,017,413 2,541 (1,860,758)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense 2,490   2,490    
Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)   157,571      
Shares issued upon vesting of restricted stock units and for exercises of stock options 351   351    
Net loss (29,764)       (29,764)
Release of cumulative translation adjustments to loss from discontinued operations 0        
Other comprehensive income (loss) $ (1,026)     (1,026)  
Balances (in shares) at Sep. 30, 2021 206,738,499 206,738,499      
Balances at Sep. 30, 2021 $ 131,247 $ 0 $ 2,020,254 $ 1,515 $ (1,890,522)